US Map / Michigan
State MI

Clinical Trials in Michigan

Recruiting clinical trials with at least one study location in Michigan. Data updated daily from ClinicalTrials.gov.

Total Trials
345
Recruiting Now
345
← Back to US Map
Top Conditions in Michigan
Advanced Solid Tumor (6)Advanced Solid Tumors (5)Glioma (4)Multiple Myeloma (4)Metastatic Breast Cancer (4)Parkinson Disease (4)Stage IVB Prostate Cancer AJCC v8 (4)Breast Cancer (4)Chronic Lymphocytic Leukemia (4)Prostate Cancer (4)Non-Small Cell Lung Cancer (3)Head and Neck Squamous Cell Carcinoma (3)

Frequently Asked Questions — Clinical Trials in Michigan

How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 345 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 345. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Advanced Solid Tumors, Glioma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Michigan

NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet...
Condition
Generalized Anxiety Disorder
Enrollment
705 pts
Location
United States, Bulgaria, Czechia
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States
Sponsor
Alkermes, Inc.
View Trial →
NCT06980480 Phase 3
Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infection...
Condition
Multiple Myeloma
Enrollment
183 pts
Location
United States, Australia, Austria
Sponsor
Takeda
View Trial →
NCT06894979 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy f...
Condition
Childhood Astrocytoma
Enrollment
54 pts
Location
United States
Sponsor
Children's Oncology Group
View Trial →
NCT07215624 N/A
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Netw...
Condition
Malignant Digestive System Neoplasm
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT07545759 Phase 2
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome...
Condition
Irritable Bowel Syndrome
Enrollment
531 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
View Trial →
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT07360418 N/A
Recruiting
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Random...
Condition
Diabetic Foot Ulcers (DFU)
Enrollment
50 pts
Location
United States
Sponsor
Applied Biologics, LLC
View Trial →
NCT02000089 Phase 3
Recruiting
The Cancer of the Pancreas Screening-5 CAPS5)Study
Condition
Pancreas Cancer
Enrollment
9,000 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06234397 Phase 1
Recruiting
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Adv...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
245 pts
Location
United States, South Korea
Sponsor
Hanmi Pharmaceutical Company L
View Trial →
NCT07321925 N/A
Recruiting
Thermoacoustic Method for Estimating Liver Fat Fraction
Condition
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Enrollment
49 pts
Location
United States
Sponsor
Endra Lifesciences
View Trial →
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
View Trial →
NCT07531745 Phase 1, Phase 2
Recruiting
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Condition
Dravet Syndrome
Enrollment
32 pts
Location
United States
Sponsor
Ionis Pharmaceuticals, Inc.
View Trial →
NCT05096481 Phase 2
Recruiting
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and...
Condition
High Grade Glioma
Enrollment
120 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT05303519 Phase 3
Recruiting
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Condition
Glioma
Enrollment
365 pts
Location
United States, Australia, China
Sponsor
Nuvation Bio Inc.
View Trial →
NCT07357428 N/A
Recruiting
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Condition
Amyotrophic Lateral Sclerosis
Enrollment
2 pts
Location
United States
Sponsor
Paradromics
View Trial →
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05869955 Phase 1
Recruiting
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Seve...
Condition
Systemic Lupus Erythematosus
Enrollment
270 pts
Location
United States, Belgium, France
Sponsor
Juno Therapeutics, Inc., a Bri
View Trial →
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
View Trial →
Page 3 of 14 — 345 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology